Pfizer To Apply For COVID-19 Booster Approval For 16-17-Year-Olds.
It was reported that Pfizer and BioNTech will seek approval for booster shots of their COVID-19 vaccine for 16 and 17-year-olds.
People familiar with the company’s plans said The Washington Post The Food and Drug Administration (FDA) is expected to quickly approve the company’s request for the additional injections.
Currently, Americans 18 years of age and older are eligible to receive booster shots six months after their second dose of the Pfizer or Moderna vaccines or two months after their single dose of the Johnson & Johnson vaccine.
The possible expansion of booster eligibility is raised as a concern surrounding the new omicron variant mount.
On Monday, President Biden said omicron “It is cause for concern, not panic”, and that closures to tackle it are not necessary.
“On Thursday, I will present a detailed strategy that outlines how we are going to fight COVID this winter, not with shutdowns or shutdowns, but with vaccines, boosters, testing and more widespread,” Biden said.
Last week, in a statement about the variant, Biden touted the booster injections and encouraged those who were eligible to receive their additional doses.
“First, for those Americans who are fully vaccinated against severe COVID disease, fortunately for the vast majority of our adults, the best way to strengthen their protection is to receive a booster shot, as soon as they are eligible,” he said.
No cases of omicron have yet been confirmed in the US, although experts believe that it will inevitably be.
